Drug class
Rifamycin Antimycobacterial
Mechanism of action
Mechanism of Action Rifabutin inhibits DNA-dependent RNA polymerase in susceptible strains of Escherichia coli and Bacillus subtilis but not in mammalian cells.
General use cases
- Tuberculosis, Pulmonary
- Mycobacterium avium-intracellulare Infection
- disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection
- Helicobacter pylori infection in adults
- Helicobacter pylori infection in adults [see Clinical Studies (14 ) ]
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
